With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio.  This allows us to have immediate scale and profitability to advance our innovative science pipeline that brings patients groundbreaking medicines across a wide spectrum of therapeutic need/critical therapeutic areas.

We continue to build a sustainable company for the long term that provides profitable growth for shareholders, financial flexibility to invest and expand our reach to help address the needs of people and communities around the world. 

Two AbbVie doctors wearing goggles and holding vials

Advancing our mission

Learn how the acquisition of Allergan allows us to better serve patients today and invest in the medicines of the future.

The Facts: AbbVie

Today, more than ever, we are well-positioned with resources and focus to deliver on our commitments and turn possibilities into reality for more patients. 

AbbVie infographic with data about worldwide presence
Infographic of conditions treated.
Research partnership infographic.
Infographic highlighting the number of countries in which AbbVie has R&D facilities
AbbVie Development Workshop Data image.
Infographic about AbbVie's Puerto Rico donations
AbbVie Quarterly Dividend infographic
AbbVie 7 Employee Resource Groups image


AbbVie is currently reviewing all content on Allergan.com.  As we work through the successful integration of Allergan and consolidation of content, information will be updated.

Media contacts


Adelle Infante
(847) 938-8745

Investor Relations
Liz Shea
(847) 935-2211

Allergan Aesthetics

Nicole Katz
(862) 219-3829